Advertisement Sorin obtains FDA approval for cardiac device - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sorin obtains FDA approval for cardiac device

Sorin Group, the European cardiovascular company and provider of medical technologies for cardiac surgery, has received the FDA approval to market the CRT model of the company's Ovatio family.

Coupled together with the Situs OTW left ventricle pacing lead, this device will now allow US physicians to treat their heart failure patients with a complete Sorin Group system.

Ovatio CRT 6750, the smallest CRT defibrillator (CRT-D) available worldwide (30cc, 11mm) is shaped to offer ease of implantation and long-term patient comfort, and is designed to allow more flexibility in the management of cardiac resynchronization and anti-tachyarrhythmia therapy, because of a unique feature – Brady-Tachy Overlap.

The Ovatio CRT will be distributed in the US by Ela Medical, a Sorin Group Company.